Autres langues Cipla Limited

Actions

CIPLA

INE059A01026

Produits pharmaceutiques

Marché Fermé - NSE India S.E. Autres places de cotation 13:05:08 04/08/2026			Varia. 5j.	Varia. 1 janv.
1 460,00 ^INR	-0,98%		+3,59%	-3,39%

28/07	Cipla Limited reçoit l'approbation de la FDA américaine pour la version générique de l'Advair Diskus	CI
24/07	CIPLA LIMITED : Jefferies & Co. est à vendre sur le dossier	ZM

Autres langues

28/07	Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus
23/07	Cipla Redesignates Global CFO to New Internal Role; Names New CFO
23/07	Cipla Limited Reports Earnings Results for the First Quarter Ended June 30, 2026
23/07	Cipla Limited Announces Cessation of Sanjay Joseph as Senior Managerial Personnel, Effective July 24, 2026
23/07	Cipla Limited Announces Global Chief Financial Officer Changes
23/07	Cipla Limited Announces Executive Changes
23/07	India's Cipla posts another profit decline, names insider Dinesh Jain CFO
22/07	Trump will Generika-Produktion mit massiven Zöllen in die USA zwingen
07/07	India finds Adani's Mumbai airport shops sold nicotine pouches in breach of law
16/06	Cipla Limited Appoints Shivam Puri as Chief Executive Officer of Its One India Business, Effective July 1, 2026
15/06	Global drugmakers invest billions to boost US presence
12/06	India raises price cap on cancer drugs to tackle shortage
11/06	Cipla's Goa, India Facility Receives VAI Status from US FDA
09/06	Indian cancer patients battle shortage of key drugs as platinum costs surge
22/05	India's Sun Pharma posts profit beat on specialty drug demand, shares slide on cost pressures
14/05	Cipla Limited announces Annual dividend, payable on July 25, 2026
13/05	Cipla Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
13/05	Indian drugmaker Cipla misses Q4 profit view on weak US sales
13/05	Cipla Q4 consol net profit 5.55 billion rupees
13/05	Cipla Limited Appoints Sushrut Kulkarni as President & Global Chief - Integrated Product Development, Effective from May 18, 2026
13/05	Indian drugmaker Cipla's fourth-quarter profit misses view on weak US sales
06/05	Cipla Limited Launches Ciposcillo Advanced Oscillometer for Respiratory Diagnostics
28/04	Pfizer secures deals to keep heart drug free of generic rivals until 2031
28/04	Pfizer reaches settlement agreements with Dexcel Pharma, Hikma & Cipla for Vyndamax
28/04	Pfizer Settles With Three Drug Manufacturers Over Alleged Patent Infringement